Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Venture capital company Arix Bioscience swung to a half-yearly loss as net asset value per share fell 14.5% thanks to a slump in Autolus' share price.
For the period ended 30 June 2019, the company reported a pre-tax loss of £44.8m, compared with a profit of £29.3m a year earlier.
Net asset value fell to £231.8m from £270.2m last year, and NAV per share declined 14.5% to 171 pence.
'The reduction in NAV for the first half of 2019 was principally due to a reduction in the share price of our largest quoted company, Autolus,' the company said.
At 9:48am: (LON:ARIX) Arix Bioscience Plc share price was 0p at 109.5p